KeyBanc
https://www.key.com/html/LP-KBCM.htmlKeyBanc Capital Markets, a subsidiary of KeyCorp (NYSE: KEY), provides investment banking and capital markets services to middle-market companies.
-
KeyBanc Upgrades BioMed Realty (BMR) to Buy
-
KeyBanc Upgrades BioMed Realty (BMR) to Hold, Overhang Could Be Lifted
-
Notable Analyst Rating Changes 05/04: (HNT) (ALL) (PSE) Upgraded; (PRU) (JPM) (PVH) Downgraded
-
JPMorgan and KeyBanc Hit 'Refresh Button' on REIT Stocks
-
KeyBanc Overweight on Specialty Office/Industrial Outlook: Favors COR & DFT
-
KeyBanc Downgrades BioMed Realty (BMR) to Underweight; Valuation Appears Rich
-
KeyBanc on REITs: Updating FFO Estimates for Several Companies Ahead of Q1
-
BioMed Realty Trust (BMR) Commences 13.5M Common Offering
-
BioMed Realty Trust (BMR) Announces Exercise of Over-Allotment in 13.23M Common Offering
-
BioMed Realty Trust (BMR) Prices 11.5M Common Offering at $17.25/Share
-
KeyBanc Downgrades BioMed Realty Trust (BMR) to Hold